No Data
RemeGen Co., Ltd.'s (HKG:9995) Shares Bounce 33% But Its Business Still Trails The Industry
Pharmaceutical stocks generally rose, with KCP Pharmaceutical (02171) increasing by 25.29%. Institutions expect that after the first quarter report, the pharmaceutical Sector is likely to see an overall performance reversal in the Industry.
Jinwu Financial News | Pharmaceutical stocks have generally risen, with Keji Pharmaceutical (02171) up 25.29%, INNOCARE (09969) up 14.58%, REMEGEN (09995) up 12.88%, Yiming Anke (01541) up 12.25%, Lepu Biopharma (02157) up 10.67%, YSB (09885) up 6.88%, and Gushengtang (02273) up 6.71%. The Hong Kong stock Pharmaceutical ETF has risen 3.59%, and the Hong Kong Stock Connect Yinhua CSI Innovative Drugs Industry ETF has risen 4.05%. Ping An Securities stated that on January 17, 2025, the National Healthcare Security Administration will hold a '
RemeGen Co., Ltd. (HKG:9995) Institutional Owners May Be Pleased With Recent Gains After 20% Loss Over the Past Year
Express News | Asco Gu｜RemeGen Announced Highly Encouraging Data From the Phase II Clinical Trial Evaluating Disitamab Vedotin Plus Immunotherapy as Perioperative Regimen for Bladder Cancer
ASCO GU|RemeGen Announced Highly Encouraging Data From the Phase II Clinical Trial Evaluating Disitamab Vedotin Plus Immunotherapy as Perioperative Regimen for Bladder Cancer
Hong Kong stock movement | REMEGEN (09995) rises over 8% again, with sales revenue in 2024 expected to exceed estimates. The company responds to the Pfizer impairment issue.
REMEGEN (09995) has risen more than 8% again, as of the time of writing, it has increased by 5.81%, priced at 15.3 Hong Kong dollars, with a trading volume of 24.852 million Hong Kong dollars.
RemeGen Co., Ltd.'s (HKG:9995) Shares Climb 29% But Its Business Is Yet to Catch Up
